Trained scent dogs can identify presence of thyroid cancer in urine
the ONA take:
A trained scent dog is able to accurately identify presence of thyroid cancer in urine samples, a recent study presented at The Endocrine Society meeting in San Diego has found.
Donald Bodenner, MD, PhD, of the University of Arkansas for Medical Sciences and colleagues acquired urine samples from 34 patients before they went on to have a biopsy for suspicious thyroid nodules Previously, Bodenner’s co-author, Arny Ferrando, PhD, scent-trained a rescued German Shepherd-mix to recognize the smell of cancer in thyroid tissue, awarding the dog for identifying cancer samples while turning away from benign ones.
When presented with the samples, the dog was able to match final surgical pathology in 30 of the 34 patients, resulting in a true-positive rate of 86.7 percent as well as a true-negative rate of 89.5 percent.
The researchers plan to expand their program in collaboration with the Auburn University College of Veterinary Medicine in order to train two bomb-sniffing dogs to also detect thyroid cancer.
A trained scent dog is able to accurately identify presence of thyroid cancer in urine samples.
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Rubraca Granted Accelerated FDA Approval for Advanced BRCA-positive Ovarian Cancer
- New Criteria for Appropriate Use of Bone Scintigraphy to Diagnose and Manage Prostate and Breast Cancer
- Primary Care Physicians Surveyed on Breast Cancer Screening Practices
- Low Acculturated Latina Women Reported Breast Cancer Treatment Experience Differently Than Other Groups
- Cost and Complication Rates Differ Among Early Breast Cancer Treatment Options
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|